Main > ONCOLOGY (**) > Prostate Cancer MET *** > Treatment > NL. F. GnRH Receptor Antagonist

---

for Inj.

NL. F. GnRH Receptor Antagonist's subsections
(*) EU Approval Date: 2009. 02.20
(*) USA Approval Date: 2008. 12.24
Company
Generic Name: Degarelix
GnRH: Gonadotropin Releasing Hormon
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 4
Patent>UpDate: 2021. 04.20.
TradeMark
TradeMark Web-Site

NL. F. GnRH Receptor Antagonist's products
This section has no products